The use of Scutellaria lateriflora: A pilot survey amongst herbal medicine practitioners

Journal of Herbal Medicine

Volumn 2, Issue 2, 2012, Pages 34-41

  Brock, Christine ^a   Whitehouse, Julie ^a   Tewfik, Ihab ^a   Towell, Tony ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Anxiolytic herbs; Medical herbalists; Scutellaria lateriflora; Skullcap; Survey

Indexed keywords

HERBACEOUS AGENT; SCUTELLARIA LATERIFLORA EXTRACT; UNCLASSIFIED DRUG;

ALLERGY; ANXIETY DISORDER; ARTICLE; COMORBIDITY; DEPRESSION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; E-MAIL; ECZEMA; ENTERITIS; EXHAUSTION; GASTROINTESTINAL SYMPTOM; HEALTH PRACTITIONER; HEALTH SURVEY; HEART PALPITATION; HERBAL MEDICINE; HUMAN; HYPERTENSION; INSOMNIA; IRELAND; MENTAL DETERIORATION; MIGRAINE; PANIC; PHOBIA; PILOT STUDY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PSORIASIS; SCUTELLARIA; SCUTELLARIA LATERIFLORA; TREATMENT RESPONSE; UNITED KINGDOM; VIVID DREAM;

EID: 84861987019     PISSN: 22108033     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hermed.2012.04.005     Document Type: Article

References (35)

1. Bates J. On the fluid extract of Scutellaria lateriflora. Boston Med Surg J 1855;52:336-7.
2. Bergner P. Traditional medicine: scullcap (Scutellaria lateriflora). Med Herb J Clin Pract 2002;13:15-7.
3. British Herbal Medicine Association. Skullcap. In: British Herbal Pharmacopoeia, editor. Bournemouth. Bournemouth, UK: British Herbal Medicine Association; 1983. p. 193-4.
4. Brock C, Whitehouse J, Tewfik I, Towell T. American skullcap (Scutellaria lateriflora): an ancient remedy for today's anxiety? Br J Wellbeing 2010;1:25-30.
5. Ciddi V, Withaferin A. From cell cultures of Withania somnifera. Indian J Pharmaceut Sci 2006;68:490-2.
6. Cole IB, Cao J, Alan AR, Saxena PK, Murch SJ. Comparisons of Scutellaria baicalensis, Scutellaria lateriflora and Scutellaria racemosa: genome size, antioxidant potential and phytochemistry. Planta Med 2008;74:474-81. (Pubitemid 351578812)
7. Cole MD, Paton AJ, Harleyl RM, Fellows LE. The significance of the iridoid glycoside, catalpol, in Scutellaria. Biochem Syst Ecol 1991;19:333-5.
8. Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res 2001;35:1347-55. (Pubitemid 32163983)
9. del Mundo WF, Shepherd WC, Marose TD. Use of alternative medicine by patients in a rural family practice clinic. Fam Med 2002;34:206-12. (Pubitemid 34208787)
10. Felter HW, Lloyd JU. Scutellaria lateriflora. In: King's American Dispensatory. Portland: Eclectic Medical Publications; 1898.
11. Gafner S, Bergeron C, Batcha LL, Reich J, Arnason JT, Burdette JE, et al. Inhibition of [3H]-LSD binding to 5-HT7 receptors by flavonoids from Scutellaria lateriflora. J Nat Prod 2003;66:535-7. (Pubitemid 36531905)
12. Gafner S, Bergeron C, Russell FE. Extract of mad-dog skullcap. US Patent application US2004/0109906A1. United States; 2004.
13. Gao J, Sanchez-Medina A, Pendry BA, Hughes MJ, Webb GP, Corcoran O. Validation of a HPLC method for flavonoid biomarkers in skullcap (Scutellaria) and its use to illustrate wide variability in the quality of commercial tinctures. J Pharm Pharmaceut Sci 2008;11:77-87.
14. Greenfield J, Davis JM. Medicinal herb production guide: skullcap (Scutellaria lateriflora L.). USA: North Carolina Consortium on Natural Medicines and Public Health; 2004.
15. Hui KM, Wang XH, Xue H. Interaction of flavones from the roots of Scutellaria baicalensis with the benzodiazepine site. Planta Med 2000;66:91-3. (Pubitemid 30097295)
16. Islam MN, Downey F, Ng CY. Comparative analysis of bioactive phytochemicals from Scutellaria baicalensis, Scutellaria lateriflora, Scutellaria racemosa, Scutellaria tomentosa and Scutellaria wrightii by LC-DAD-MS. Metabolomics 2011;7:446-53.
17. Jia Q, Nichols TC, Rhoden EE, Waite S. Identification of free-B-ring flavonoids as potent COX-2 inhibitors. US Patent application US20070135359 A1. United States; 2007.
18. Joshee N, Patrick TS, Mentreddy RS, Yadav AK. Skullcap: potential medicinal crop. In: Janick J, Whipkey A, editors. Trends in new crops and new uses. Alexandria, VA: ASHS Press. p. 580-6.
19. LaGarce R, Kuhn LD. The effect of visual stimuli on mail survey response rates. Ind Market Manag 1995;24:11-8.
20. Li J, Wang Y-H, Smillie TJ, Khan IA. Identification of phenolic compounds from Scutellaria lateriflora by liquid chromatography with ultraviolet photodiode array and electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 2012;63:120-7.
21. Liao JF, Wang HH, Chen MC, Chen CC, Chen CF. Benzodiazepine binding site-interactive flavones from Scutellaria baicalensis root. Planta Med 1998;64:571-2.
22. Lloyd JU. History of the vegetable drugs of the USP. In: Lloyd JU, Lloyd CG, editors. Bulletin of the Lloyd's Library of Botany, Pharmacy and Materia Medica 18. Cincinnati: Lloyd & Lloyd; 1911. p. 109.
23. Makino T, Hishida A, Goda Y, Mizukami H. Comparison of the major flavonoid content of S. baicalensis, S. lateriflora, and their commercial products. J Nat Med 2008;62:294-9.
24. Malikov VM, Yuldashev MP. Phenolic compounds of plants of the Scutellaria L. Genus. Distribution, structure, and properties. Chem Nat Compd 2002;38:358-406.
25. Millspaugh CF. Scutellaria. In: Medicinal plants. Philadelphia: John C. Yorston and Company; 1892. p. 469-72.
26. Natural Medicines Comprehensive Database. Skullcap (Scutellaria lateriflora). Stockton, CA: Therapeutic Research Faculty; 2011. Available from: http://naturaldatabase.therapeuticresearch. com [date accessed 22/11/2011].
27. New Jersey Historical Society. Manuscript Group 481, Van Derveer Family Papers, 1733-1908. Archives. Newark, NJ; 2001. Available from: http://www.jerseyhistory.org/findingaid. php?aid=0481 [date accessed 21/11/2011].
28. Paladini AC, Marder M, Viola H, Wolfman C, Wasowski C, Medina JH. Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds. J Pharm Pharmacol 1999;51:519-26. (Pubitemid 29319776)
29. Rabow LE, Russek SJ, Farb DH. From ion currents to genomic analysis: recent advances in GABAA receptor research. Synapse 1995;21:189-274.
30. Shang X, He X, Li M, Zhang R, Fan P, Zhang Q, Jia Z. The genus Scutellaria an ethnopharmacological and phytochemical review. J Ethnopharmacol 2010;128:279-313.
31. USDA. Plants profile: Scutellaria lateriflora L. (blue skullcap). Plants database. USA: United States Department of Agriculture Natural Resources Conservation Service; 2012. Available from: http://plants.usda.gov/java/profile? symbol=SCLA2 [date accessed 11/7/2011].
32. Upton R, Graff A, Soria T, Swisher D. American Herbal Pharmacopoeia and Therapeutic Compendium: skullcap aerial parts. Scutellaria lateriflora L. Standards of analysis, quality control and therapeutics. Scotts Valley, California: American Herbal Pharmacopoeia; 2009.
33. Wills RBH, Stuart DL. Generation of high quality Australian skullcap products. RIRDC Publication No. 04/020. Kingston, ACT: Rural Industries Research and Development Corporation; 2004.
34. Wolfson P, Hoffmann DL. An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers. Altern Ther Health Med 2003;9:74-8. (Pubitemid 36286409)
35. Zhang Z, Lian XY, Li S, Stringer JL. Characterization of chemical ingredients and anticonvulsant activity of American skullcap (Scutellaria lateriflora). Phytomedicine 2009;16:485-93.